Adaptive Biotechnologies Announces Grand Opening of State-of-the-Art Headquarters and Expands Footprint in Seattle

NEXT STORY
Rhythm Pharmaceuticals Announces Marketing Authorisation of IMCIVREE® (setmelanotide) in Great Britain
PREV STORY
Vaxcyte to Present at 2021 Cantor Virtual Global Healthcare Conference
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

SANOFI AND ABLYNX ANNOUNCE THE SUCCESSFUL RESULTS OF THE INITIAL TENDER OFFER PERIOD FOR ABLYNX AND COMMENCEMENT OF SQUEEZE-OUT TENDER PERIOD

Paris, France and Ghent, Belgium - May 14, 2018 - Sanofi [Euronext: SAN; NYSE: ...

author_avatar
NASDAQ Market News

21st Century Oncology Receives Court Approval of Plan of Reorganization

FORT MYERS, Fla., Jan. 09, 2018 (GLOBE NEWSWIRE) -- 21st Century Oncology Holdings, Inc., ...

author_avatar
NASDAQ Market News

Myriad Announces Positive Results for an EndoPredict® Clinical Study Published in the Journal of the National Cancer Institute

SALT LAKE CITY and COLOGNE, Germany, July 11, 2016 (GLOBE NEWSWIRE) -- Myriad Genetics, ...

author_avatar
NASDAQ Market News